90 related articles for article (PubMed ID: 378368)
1. Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful).
Benvenuto JA; Liehr JG; Winkler T; Farquhar D; Caprioli RM; Loo TL
Cancer Res; 1979 Aug; 39(8):3199-201. PubMed ID: 378368
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
Wu AT; Au JL; Sadée W
Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
[TBL] [Abstract][Full Text] [Related]
3. Studies on tetrahydrofuranyl-5-fluorouracils. 2. NMR studies of 1-(tetrahydro-2-furanyl)-, 3-(tetrahydro-2-furanyl)-, and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracils.
Yasumoto M; Ueda S; Yamashita J; Hashimoto S
Nucleic Acids Symp Ser; 1979; (6):s85-8. PubMed ID: 121157
[TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of ftorafur metabolites. 3'- and 4'-hydroxyftorafur.
Lin AJ; Benjamin RS; Rao PN; Loo TL
J Med Chem; 1979 Sep; 22(9):1096-100. PubMed ID: 385879
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure, and conformation of anti-tumor agents in the solid and solution states: hydroxyl derivatives of Ftorafur.
Stokes DM; Paul B; Alderfer JL; Wollman RM; Srikrishnan T
Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):863-82. PubMed ID: 12537027
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.
Au JL; Sadée W
Cancer Res; 1979 Oct; 39(10):4289-90. PubMed ID: 383283
[No Abstract] [Full Text] [Related]
8. [Study of energy characteristics of 5-fluorouracil analogs by photoionization mass-spectrometry].
Orlov VM; Pustobaev VN; Mikhaĭlov SN; Varshavskiĭ IaM; Ludzina AS
Bioorg Khim; 1984 Apr; 10(4):528-35. PubMed ID: 6497910
[TBL] [Abstract][Full Text] [Related]
9. Structure of two hydroxylated metabolites of ftorafur.
Meyer RB; Levenson CH
Biochem Pharmacol; 1980 Feb; 29(4):665-8. PubMed ID: 6768366
[No Abstract] [Full Text] [Related]
10. Metabolism, antitumor activity, and acute toxicity of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione by oral administration to animals.
Fujii S; Nakamura Y; Takeda S; Morita K; Sato T; Marunaka T; Kawaguchi Y; Unemi N
Gan; 1980 Feb; 71(1):30-44. PubMed ID: 6769737
[TBL] [Abstract][Full Text] [Related]
11. High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.
Marunaka T; Umeno Y; Yoshida K; Nagamachi M; Minami Y; Fujii S
J Pharm Sci; 1980 Nov; 69(11):1296-300. PubMed ID: 6778988
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil in mice.
Fujimoto S; Ishigami H; Minami T; Miyazaki M; Itoh K; Kimura K
J Natl Cancer Inst; 1979 Aug; 63(2):465-8. PubMed ID: 379401
[TBL] [Abstract][Full Text] [Related]
13. Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
Yasumoto M; Yamawaki I; Marunaka T; Hashimoto S
J Med Chem; 1978 Aug; 21(8):738-41. PubMed ID: 357721
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes.
El Sayed YM; Sadée W
Cancer Res; 1983 Sep; 43(9):4039-44. PubMed ID: 6409396
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
Yamada Y; Miyauchi S; Unemi N
J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).
Au JL; Sadée W
Cancer Chemother Pharmacol; 1981; 7(1):55-9. PubMed ID: 6804104
[No Abstract] [Full Text] [Related]
18. Quantitative determination of 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione and its metabolites in visceral tissues by high-performance liquid chromatography and gas chromatography-mass fragmentography.
Marunaka T; Umeno Y; Minami Y
J Chromatogr; 1980 Jan; 188(1):270-2. PubMed ID: 6769934
[No Abstract] [Full Text] [Related]
19. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
Au JL; Sadée W
Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
[No Abstract] [Full Text] [Related]
20. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
Harvey DJ; Marriage HJ
Drug Metab Dispos; 1987; 15(6):914-20. PubMed ID: 2893721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
